vs
CROWN CRAFTS INC（CRWS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是CROWN CRAFTS INC的1.7倍（$35.5M vs $20.7M），CROWN CRAFTS INC净利率更高（7.3% vs -304.2%，领先311.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -11.3%），CROWN CRAFTS INC自由现金流更多（$2.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -6.7%）
皇冠工艺品公司是一家美国上市企业，总部位于路易斯安那州冈萨雷斯，主营婴幼儿及青少年消费品的设计、营销与分销业务，公司股票在纳斯达克资本市场挂牌交易，股票代码为CRWS。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CRWS vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.7倍
$20.7M
营收增速更快
RXRX
高出693.0%
-11.3%
净利率更高
CRWS
高出311.5%
-304.2%
自由现金流更多
CRWS
多$49.7M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-6.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.7M | $35.5M |
| 净利润 | $1.5M | $-108.1M |
| 毛利率 | 23.5% | 59.8% |
| 营业利润率 | -0.5% | -304.8% |
| 净利率 | 7.3% | -304.2% |
| 营收同比 | -11.3% | 681.7% |
| 净利润同比 | 69.1% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRWSRXRX
| Q4 25 | $20.7M | $35.5M | ||
| Q3 25 | $23.7M | $5.2M | ||
| Q2 25 | $15.5M | $19.2M | ||
| Q1 25 | $23.2M | $14.7M | ||
| Q4 24 | $23.4M | $4.5M | ||
| Q3 24 | $24.5M | $26.1M | ||
| Q2 24 | $16.2M | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润CRWSRXRX
| Q4 25 | $1.5M | $-108.1M | ||
| Q3 25 | $1.2M | $-162.3M | ||
| Q2 25 | $-1.1M | $-171.9M | ||
| Q1 25 | $-10.8M | $-202.5M | ||
| Q4 24 | $893.0K | $-178.9M | ||
| Q3 24 | $860.0K | $-95.8M | ||
| Q2 24 | $-322.0K | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率CRWSRXRX
| Q4 25 | 23.5% | 59.8% | ||
| Q3 25 | 27.7% | -183.8% | ||
| Q2 25 | 22.7% | -4.9% | ||
| Q1 25 | 18.3% | -48.0% | ||
| Q4 24 | 26.1% | -181.4% | ||
| Q3 24 | 28.4% | 53.7% | ||
| Q2 24 | 24.5% | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率CRWSRXRX
| Q4 25 | -0.5% | -304.8% | ||
| Q3 25 | 7.9% | -3327.6% | ||
| Q2 25 | -7.7% | -916.8% | ||
| Q1 25 | -60.7% | -1297.9% | ||
| Q4 24 | 7.3% | -4042.4% | ||
| Q3 24 | 6.2% | -377.1% | ||
| Q2 24 | -1.8% | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率CRWSRXRX
| Q4 25 | 7.3% | -304.2% | ||
| Q3 25 | 4.9% | -3135.3% | ||
| Q2 25 | -7.1% | -894.2% | ||
| Q1 25 | -46.4% | -1373.3% | ||
| Q4 24 | 3.8% | -3935.5% | ||
| Q3 24 | 3.5% | -367.5% | ||
| Q2 24 | -2.0% | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）CRWSRXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | $-0.10 | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | $-0.03 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $39.2M | $1.1B |
| 总资产 | $76.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CRWSRXRX
| Q4 25 | $2.4M | $743.3M | ||
| Q3 25 | $810.0K | $659.8M | ||
| Q2 25 | $227.0K | $525.1M | ||
| Q1 25 | $521.0K | $500.5M | ||
| Q4 24 | $1.1M | $594.4M | ||
| Q3 24 | $2.0M | $427.6M | ||
| Q2 24 | $1.1M | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务CRWSRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益CRWSRXRX
| Q4 25 | $39.2M | $1.1B | ||
| Q3 25 | $38.4M | $1.0B | ||
| Q2 25 | $37.9M | $919.1M | ||
| Q1 25 | $39.6M | $933.9M | ||
| Q4 24 | $51.1M | $1.0B | ||
| Q3 24 | $50.8M | $524.6M | ||
| Q2 24 | $50.7M | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产CRWSRXRX
| Q4 25 | $76.1M | $1.5B | ||
| Q3 25 | $77.5M | $1.4B | ||
| Q2 25 | $76.0M | $1.3B | ||
| Q1 25 | $81.2M | $1.3B | ||
| Q4 24 | $98.7M | $1.4B | ||
| Q3 24 | $99.3M | $726.5M | ||
| Q2 24 | $76.4M | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比CRWSRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 11.3% | -133.1% |
| 资本支出强度资本支出/营收 | 1.7% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.78× | — |
| 过去12个月自由现金流最近4个季度 | $9.1M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流CRWSRXRX
| Q4 25 | $2.7M | $-46.1M | ||
| Q3 25 | $-845.0K | $-117.4M | ||
| Q2 25 | $5.2M | $-76.4M | ||
| Q1 25 | $2.8M | $-132.0M | ||
| Q4 24 | $-36.0K | $-115.4M | ||
| Q3 24 | $-983.0K | $-59.2M | ||
| Q2 24 | $8.0M | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流CRWSRXRX
| Q4 25 | $2.3M | $-47.3M | ||
| Q3 25 | $-1.0M | $-117.6M | ||
| Q2 25 | $5.2M | $-79.6M | ||
| Q1 25 | $2.6M | $-133.8M | ||
| Q4 24 | $-220.0K | $-116.7M | ||
| Q3 24 | $-1.2M | $-63.8M | ||
| Q2 24 | $7.7M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率CRWSRXRX
| Q4 25 | 11.3% | -133.1% | ||
| Q3 25 | -4.3% | -2272.5% | ||
| Q2 25 | 33.4% | -413.9% | ||
| Q1 25 | 11.3% | -907.4% | ||
| Q4 24 | -0.9% | -2567.7% | ||
| Q3 24 | -4.8% | -244.6% | ||
| Q2 24 | 47.7% | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度CRWSRXRX
| Q4 25 | 1.7% | 3.5% | ||
| Q3 25 | 0.7% | 4.7% | ||
| Q2 25 | 0.6% | 16.4% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 0.8% | 28.6% | ||
| Q3 24 | 0.8% | 17.5% | ||
| Q2 24 | 1.8% | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率CRWSRXRX
| Q4 25 | 1.78× | — | ||
| Q3 25 | -0.73× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.04× | — | ||
| Q3 24 | -1.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
